Yoshitoku Yoshida1, Yumei Zhang, Yasuko Yoshida, Defu Ma, Peiyu Wang. 1. Young Leaders' Program of Health Care Administration, Graduate School of Medicine, Nagoya University, Nagoya, Aichi 466-8550, Japan. yoshidayoshitoku@med.nagoya-u.ac.jp
Abstract
PURPOSE: This study investigated the current quality of clinical trials conducted in China. METHODS: Questionnaires were administered to medical doctors belonging to institutes affiliated to Peking University in Beijing, China. The delivery and collection of questionnaires were conducted by a research team from China. Analysis and evaluation were conducted by research teams from both China and Japan. RESULTS: A total of 145 questionnaires were administered and 117 respondents included the name of the medical institution to which they belonged. A total of 56.3% of the respondents participated in audit and inspection by institutes and 50.5% of the respondents reported receipt of the audit findings. A further 23.6% participated in audits and inspections performed by an external authority and 20.2% reported the receipt of the audit findings. CONCLUSION: Our research suggests that clinical trials in Beijing are well conducted and are monitored by both institutions and external authorities.
PURPOSE: This study investigated the current quality of clinical trials conducted in China. METHODS: Questionnaires were administered to medical doctors belonging to institutes affiliated to Peking University in Beijing, China. The delivery and collection of questionnaires were conducted by a research team from China. Analysis and evaluation were conducted by research teams from both China and Japan. RESULTS: A total of 145 questionnaires were administered and 117 respondents included the name of the medical institution to which they belonged. A total of 56.3% of the respondents participated in audit and inspection by institutes and 50.5% of the respondents reported receipt of the audit findings. A further 23.6% participated in audits and inspections performed by an external authority and 20.2% reported the receipt of the audit findings. CONCLUSION: Our research suggests that clinical trials in Beijing are well conducted and are monitored by both institutions and external authorities.
Authors: Cheryl A Fisher; Catherine A Griffith; Hyacinth Lee; Hazel A Smith; Carolynn T Jones; Kathleen A Grinke; Rosemary Keller; Georgie Cusack; Shaunagh Browning; Gordon Hill Journal: J Res Nurs Date: 2022-04-01